Mountainfield Venture Partners

Location on request

Check size

🔒 $•• – $••

+ Save to my list

Healthcare & Biotechhealthcare

Partners & team

1 contact on file

SS

Siyu Shi

Partner · Primary contact

LinkedIn profile

Sign up free to unlock contact →

Mountainfield Venture Partners in the news

citybiz
cAMPfield Therapeutics Launches With $180M Series A
3 months ago
The Pharma Letter
cAMPfield launches with $180 million Series A financing
3 months ago
Fierce Biotech
cAMPfield harvests $180M series A to advance oral IBD drug licensed from Newsoara
3 months ago
BioSpace
New biotech cAMPfield emerges with $180M to reshape IBD treatment
3 months ago
PR Newswire
cAMPfield Launches With $180 Million Series A to Advance Prifemilast, a Potential Best-in-Class Oral Therapy for IBD
3 months ago
The Manila Times
Catalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of Directors
Aug 2025
Fierce Biotech
InnoCare, Keymed sell ex-China rights for bispecific to RTW-built biotech in $520M deal
Jan 2025
BioWorld News
Newco Prolium licenses antibody from Innocare, Keymed for $520M
Jan 2025
Inside Precision Medicine
Timberlyne Therapeutics Launched Last Week with a $180 Million Series A Financing
Jan 2025
FirstWord Pharma
Timberlyne debuts with $180M series A to advance CD38-directed antibody
Jan 2025
Fierce Biotech
Biotech creator and China's Keymed launch antibody company with $180M series A
Jan 2025
PR Newswire
Timberlyne Therapeutics Launches with a $180 Million Series A Financing to Advance CM313, a Potentially Best-in-Class Anti-CD38 Monoclonal Antibody, for Diseases of High Unmet Medical Needs
Jan 2025

Add Mountainfield Venture Partners to your investor list

Sign up free to save investors, see partner contacts, and track your raise.